SYK Inhibitors for the Treatment of ITP

Weill Cornell Medicine Oncology & Hematology

J. Bussel

Fostamatinib in the Treatment of Chronic ITP

Aron Kefela

Second Line Therapy for ITP

Amy Zhou

UC Denver ASH Review: Updates on Benign Hematology

University of Colorado Division of Hematology

A. Metjian

Hematologic irAEs (VTEs)

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

K. McCrae

ASH 2021 Highlights on Thrombosis and Anticoagulation

Yale Cancer Center

A. Pine

Managing Hematologic Toxicities From Immunotherapeutic Agents

Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

M. Jaglal

Venous Thromboembolism in Lymphoma: Risk Stratification, Prophylaxis…

19th Annual International Ultmann Chicago Lymphoma Symposium

K. Cohen

Thrombotic Microangiopathies: Modern Diagnosis and Treatments

Rush University Medical Center

S. Cataland

Benign Hematology: Clotting, Bleeding, and More

Indy Hematology Review

C. Kessler